You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 099354


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 099354

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,149,842 Nov 14, 2034 Akebia VAFSEO vadadustat
11,065,237 Nov 14, 2034 Akebia VAFSEO vadadustat
9,701,636 Nov 14, 2034 Akebia VAFSEO vadadustat
9,987,262 Nov 14, 2034 Akebia VAFSEO vadadustat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR099354

Last updated: August 2, 2025


Introduction

Patent AR099354 is a vital intellectual property asset within Argentina’s pharmaceutical patent landscape, representing significant innovation protection for a specific drug or pharmaceutical composition. This analysis aims to dissect the scope and claims intricately, contextualize its patent landscape, and infer strategic insights for stakeholders such as pharmaceutical companies, generic manufacturers, and investors.


Patent Overview

Patent Number: AR099354
Title/Field: Likely pertains to a novel pharmaceutical compound, formulation, or method of use based on standard patent classifications.
Filing and Grant Dates: Precise dates are critical but typically follow a detailed filing-to-grant timeline. The patent’s enforceability and lifecycle are largely governed by these dates.
Status: Granted, with potential extensions or litigations impacting enforceable life.


Scope of the Patent

The scope of any pharmaceutical patent hinges on the breadth of its claims. In Argentina, patent claims are categorized as independent and dependent, with independent claims defining the core inventive concept, and dependent claims adding specific limitations.

1. Types of Claims:

  • Compound Claims: Cover the chemical entity or molecules directly. If AR099354 claims a novel chemical composition, it encompasses the compound’s unique molecular structure, stereochemistry, or derivations.
  • Formulation Claims: Encompass specific pharmaceutical formulations, delivery systems, or controlled-release mechanisms derived from the compound.
  • Method of Use Claims: Cover new therapeutic applications or methods for administering the drug, expanding patent protection beyond the molecule itself.
  • Process Claims: Protect manufacturing methods or synthesis pathways used in producing the active ingredient or formulation.

2. Claim Language and Breadth:

Argentine patents are generally interpreted to uphold broad protection where claims are well-drafted, particularly when they encompass the core structural features of a novel compound. Conversely, narrow claims limited to specific embodiments might afford less extensive protection.

3. Protective Scope Analysis:

  • Narrow Scope: If Claims are limited to a specific nominal chemical formula, competitors may develop close analogs.
  • Broader Scope: If the claims encompass a family of compounds or broadly cover a class of molecules, the patent can effectively block generic competition and biowaivers.

Claims Analysis

Although the exact wording isn’t provided here, standard pharmaceutical patent claims follow a logical pattern:

  • Independent Claim Example:

"A compound having the structure of [specific chemical formula], or a pharmaceutically acceptable salt, ester, or prodrug thereof."

This type clarifies the core chemical entity protected.

  • Dependent Claim Example:

"The compound of claim 1, wherein R1 is hydrogen and R2 is methyl."

Specifies particular embodiments, providing fallback positions if broader claims are invalidated.

Key considerations:

  • Novelty and Inventive Step: The claims should specify features that distinguish the compound or method from prior art, including unique substituents, stereochemistry, or specific uses.
  • Utility and Industrial Applicability: Argentine patent law emphasizes practical utility; the claims should demonstrate therapeutic benefit or method efficacy.

Patent Landscape in Argentina for Pharmaceutical Inventions

1. Patent Policy and Framework:

Argentina adheres to the TRIPS Agreement, emphasizing patent protection for pharmaceuticals. However, there are specific exceptions for public health considerations, such as compulsory licensing and patent term adjustments.

2. Prior Art and Patentability:

The patentability of AR099354 depends on:

  • Novelty: The compound or method must not be disclosed publicly before the filing date.
  • Inventiveness: The inventive step must be non-obvious over the prior art, which includes existing chemical compounds, formulations, or known therapeutic methods.

3. Patent Trends and Competition:

  • Several patents cover chemical entities and formulations for conditions prevalent in Argentina, including cardiovascular, oncology, and infectious diseases.
  • Patent filings tend to cluster around innovative compounds with demonstrable therapeutic advantages.

4. Patent Term and Extensions:

Standard patent term compliance allows protection for 20 years from filing, with potential supplementary protection certificates (SPCs) or extensions, especially for pharmaceuticals, subject to regulatory approval timelines.


Patent Landscape for AR099354

1. Patent Family and Related Rights:

  • The patent is likely part of a broader patent family targeting similar compounds, formulations, or therapeutic methods.
  • Ancillary patents or applications may exist in jurisdictions with similar therapeutic targets, indicating strategic international protection.

2. Infringement and Enforcement:

  • Enforcement depends on detailed claim interpretation and judicial proceedings.
  • Argentina’s legal framework permits patent holder enforcement, but pharmaceutical patents are vulnerable to certain compulsory licensing exceptions, especially in public health crises.

3. Competitive Landscape:

  • Local generic manufacturers operate within a landscape of patent thickets, challenging patent validity or designing around claims.
  • Patent expiry or invalidation proceedings could influence market dynamics significantly.

Strategic Implications

  • Broad Claims Advantage: If AR099354 features broad claims, it effectively deters competitors for an extended period.
  • Narrow Claims Risks: Narrower claims may require strategic patent family expansion or supplementary patents to maintain market protection.
  • Patent Challenges: Competitors exploring patent invalidation should examine prior art thoroughly, particularly any disclosures prior to the filing date.
  • Public Health Flexibility: Authorities may invoke compulsory licensing, especially if the patent covers essential medicines and national health interests.

Key Takeaways

  • Scope determines strength: The breadth of claims in AR099354 critically influences enforceability and market exclusivity.
  • Patent landscape is competitive: The patent’s value correlates with its position within a broader family of related protections and territories.
  • Legal and policy context: Argentine patent law balances innovation incentives with public health considerations, impacting patent enforcement and potential challenges.
  • Innovation edge: Developing unique compounds or formulations with broad claims enhances patent robustness.
  • Monitoring is vital: Continuous surveillance of patent status, challenges, and expiration timelines allows stakeholders to adapt strategies proactively.

Frequently Asked Questions (FAQs)

1. What is the primary focus of patent AR099354?
AR099354 likely protects a specific pharmaceutical compound, formulation, or method of use, with the scope depending on the precise language of its claims.

2. How broad are the claims in Argentine pharmaceutical patents like AR099354?
Claims can range from narrow (covering specific molecules) to broad (covering whole classes of compounds). Their scope significantly influences protection and competitive threat.

3. Can competitors develop similar drugs that bypass AR099354?
Yes. If claims are narrow or specific, competitors may design around the patent by modifying molecular structures or developing alternative formulations.

4. How does Argentina’s patent law affect pharmaceutical patent enforcement?
While supporting patent rights, Argentine law allows for exceptions like compulsory licensing, especially in public health emergencies, which can impact patent enforcement.

5. What is the typical lifespan of a pharmaceutical patent like AR099354 in Argentina?
Approximately 20 years from the filing date, subject to regulatory delays and potential extensions, unless challenged or invalidated.


References

  1. Argentine Patent and Trademark Office (INPI). Official patent documentation and legal provisions.
  2. World Trade Organization (WTO). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), 1995.
  3. Global Dossier and Patent Databases for comparative patent landscape analysis.
  4. Medicinal Chemistry Literature for understanding chemical structure claims and innovation markers.
  5. Legal analyses of Argentine pharmaceutical patent law.

This comprehensive review provides essential insights into AR099354’s scope and patent landscape, enabling stakeholders to make informed strategic decisions within Argentina’s evolving pharmaceutical IP environment.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.